NCT04597723

Brief Summary

Carbon dioxide which is insufflated to inflate the abdominal area is absorbed from the peritoneal area and it increases endogenous catecholamines, which may consequently increase nausea and vomiting. In the literature, it is indicated that oxygen application which is one of the applications aiming to prevent nausea and vomiting is a cheap method with fewer side effects in the prevention of postoperative nausea and vomiting. In the literature, studies on the prevention of nausea and vomiting by oxygen application in different surgical interventions have not arrived at a consensus regarding surgery type and oxygen amounts. There are studies evaluating 80% and 30% oxygen amounts in removing postoperative nausea and vomiting. Taking these conditions into consideration; the study has been planned for the purpose of examining the impact of giving 80% and 60% oxygen to patients to whom laparoscopic cholecystectomy is applied on postoperative nausea and vomiting in the postoperative period. The study has been planned as a randomized controlled study for the purpose of determining the impact of giving oxygen (80% to the group A, 60% to the group B and control group C) to patients who apply to the general surgery service to undergo a laparoscopic cholecystectomy on postoperative nausea and vomiting in the postoperative period. The patients in the study will have the same standard anesthesia protocol and hospital routine. The study will be terminated once a total of 111 patients have been reached. In the study randomization, the patients will be assigned to the sample group according to weeks as they may influence each other. Data will be collected using Patient Introductory Information Form, which evaluates patients' socio-demographic characteristics, as well as Perioperative Period Patient Follow-Up Form and Postoperative Period Nausea-Vomiting Frequency and Severity Evaluation Form. Statistical analysis of the data to be acquired as a result of the study will be performed in the computer environment. The results to be obtained will be evaluated at p\<0,05 significance level. It is expected that the study results will provide an alternative method, which will be used in preventing the possible side effects of postoperative nausea and vomiting in patients who undergo a laparoscopic cholecystectomy. Thus, the study results may make scientific and socio-economic contributions.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
111

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started May 2022

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 15, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 22, 2020

Completed
1.5 years until next milestone

Study Start

First participant enrolled

May 3, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 3, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 3, 2023

Completed
Last Updated

October 22, 2020

Status Verified

October 1, 2020

Enrollment Period

8 months

First QC Date

October 15, 2020

Last Update Submit

October 21, 2020

Conditions

Keywords

postoperative nausea and vomitingOxygen

Outcome Measures

Primary Outcomes (2)

  • severity of nausea

    severity of nausea was measured using a 10-cm visual analog scale, The patients were explained that 1 point indicated "no nausea" and 10 points indicated "severe nausea," and then they were asked to give 1-10 points for their severity of nausea.

    0-24 hours in the postoperative period

  • severity of vomiting

    severity of vomiting was measured using a 10-cm visual analog scale, The patients were explained that 1 point indicated "no vomiting" and 10 points indicated "severe vomiting," and then they were asked to give 1-10 points for their severity of vomiting

    0-24 hours in the postoperative period

Study Arms (3)

80% oxygen

EXPERIMENTAL

80% oxygen given group

Drug: oxygen

60% oxygen

EXPERIMENTAL

60% oxygen given group

Drug: oxygen

routine hospital care

NO INTERVENTION

The patients in this group received routine hospital care.

Interventions

oxygenDRUG

Patients will be given different concentrations of oxygen.

60% oxygen80% oxygen

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Surgery time is 2 hours or less
  • The patient does not have peripheral vascular disease
  • The patient does not have a psychiatric disorder
  • The patient can communicate verbally
  • The patient is not using anticoagulant drugs
  • The patient's hemoglobin level in the preoperative period is in the range of 12-16 g / dL
  • The patient's American Society of Anesthesiologist (ASA) value is between 1-2
  • The patient is not smoking
  • The patient is between 18 and 65 years old
  • In the intraoperative period, the carbon dioxide gas pressure used to inflate the abdomen is between 10-12.
  • The patient's willingness to participate in the research
  • The patient does not have respiratory diseases (such as bronchitis)
  • The patient does not have claustrophobia

You may not qualify if:

  • \- The patient is using anticoagulant medication

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pınar tunç tuna

Konya, 42500, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Postoperative Nausea and Vomiting

Interventions

Oxygen

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNauseaSigns and Symptoms, DigestiveSigns and SymptomsVomiting

Intervention Hierarchy (Ancestors)

ChalcogensElementsInorganic ChemicalsGases

Study Officials

  • Hulya Bulut

    Gazi University

    STUDY CHAIR
  • Sevil Guler Demir

    Gazi University

    STUDY CHAIR
  • Faruk Cicekci

    Selcuk University

    STUDY CHAIR
  • Hulagu Barıskaner

    Selcuk University

    STUDY CHAIR
  • Mustafa Sahin

    Selcuk University

    STUDY CHAIR
  • Inci Kara

    Selcuk University

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 15, 2020

First Posted

October 22, 2020

Study Start

May 3, 2022

Primary Completion

January 3, 2023

Study Completion

May 3, 2023

Last Updated

October 22, 2020

Record last verified: 2020-10

Locations